Riverpark Advisors Lowers stake in Monsanto Company (MON)

Monsanto Company (MON) : Riverpark Advisors reduced its stake in Monsanto Company by 17.75% during the most recent quarter end. The investment management company now holds a total of 17,755 shares of Monsanto Company which is valued at $1,852,912 after selling 3,832 shares in Monsanto Company , the firm said in a disclosure report filed with the SEC on Aug 1, 2016.Monsanto Company makes up approximately 0.85% of Riverpark Advisors’s portfolio.

Other Hedge Funds, Including , Uss Investment Management Ltd reduced its stake in MON by selling 270,000 shares or 27.33% in the most recent quarter. The Hedge Fund company now holds 718,000 shares of MON which is valued at $74,930,480. Monsanto Company makes up approx 1.24% of Uss Investment Management Ltd’s portfolio.John G Ullman Associates Inc boosted its stake in MON in the latest quarter, The investment management firm added 2,000 additional shares and now holds a total of 45,090 shares of Monsanto Company which is valued at $4,765,111. Monsanto Company makes up approx 0.94% of John G Ullman Associates Inc’s portfolio.Checchi Capital Advisers boosted its stake in MON in the latest quarter, The investment management firm added 78 additional shares and now holds a total of 3,219 shares of Monsanto Company which is valued at $340,184. Monsanto Company makes up approx 0.08% of Checchi Capital Advisers’s portfolio.

Monsanto Company opened for trading at $104.36 and hit $106.94 on the upside on Thursday, eventually ending the session at $106.42, with a gain of 1.97% or 2.06 points. The heightened volatility saw the trading volume jump to 49,51,389 shares. Company has a market cap of $46,567 M.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.